Valeant Securities Settlement
Holding Companies & Conglomerates · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 301133, Los Angeles, California, ...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Valeant Securities Settlement
Valeant Pharmaceuticals International, Inc., now known as Bausch Health Companies Inc., was involved in a significant securities litigation case concerning alleged violations of federal securities laws. The litigation, led by TIAA as the Lead Plaintiff, alleges that Valeant and other defendants made materially false and misleading statements regarding the company's operations and financial performance, which resulted in significant damages to investors. As a result of the lawsuit, a settlement fund of $1,210,000,000 was proposed for eligible class members who purchased Valeant securities during a specified period. The intended clients include all individuals and entities that acquired Valeant common stock or securities during the specified time frame and suffered financial loss.Explore more
Popular SearchesValeant Securities SettlementSIC Code 67,671NAICS Code 55,551Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Valeant Securities Settlement your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Valeant Securities Settlement is spiking on competitors!
Check if Valeant Securities Settlement has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Valeant Securities Settlement recently announced quarterly report
Funding: Get notified immidiatlly once Valeant Securities Settlement has new funding data
Valeant Securities Settlement, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Valeant Securities Settlement had a recent Job posting/layoffs
Product Launch: Get notified when Valeant Securities Settlement launches new products
Congratulate Masked Content for being promoted to Masked Content at Valeant Securities Settlement
Recommended Actions
Find VP level buyers at Valeant Securities Settlement
Find more new buyers
Compare Similar Companies to Valeant Securities Settlement
Compare insights from companies similar to Valeant Securities Settlement, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Valeant Securities Settle...
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Valeant Securities Settlement is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
Valeant Securities Settlement is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Valeant Securities Settlement.
Valeant Securities Settlement Tech Stack
A closer look at the technologies used by Valeant Securities Settlement
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Valeant Securities Settlement
Sign Up For FreeTo access detailed company insights
Valeant Pharmaceuticals International, Inc., now known as Bausch Health Companies Inc., was involved in a significant securities litigation case concerning alleged violations of federal securities laws. The litigation, led by TIAA as the Lead Plaintiff, alleges that Valeant and other defendants made materially false and misleading statements regard... Read More
